Cargando…
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Despite great success in cancer immunotherapy, immune checkpoint-targeting drugs are not the most popular weapon in the armory of cancer therapy. Accumulating evidence suggests that the tumor immune microenvironment plays a critical role in anti-cancer immunity, which may result in immune checkpoint...
Autores principales: | Tang, Tianyu, Huang, Xing, Zhang, Gang, Hong, Zhengtao, Bai, Xueli, Liang, Tingbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896069/ https://www.ncbi.nlm.nih.gov/pubmed/33608497 http://dx.doi.org/10.1038/s41392-020-00449-4 |
Ejemplares similares
-
Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy
por: Huang, Xing, et al.
Publicado: (2020) -
VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
por: Huang, Xing, et al.
Publicado: (2020) -
Calreticulin couples with immune checkpoints in pancreatic cancer
por: Huang, Xing, et al.
Publicado: (2020) -
Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity
por: Huang, Xing, et al.
Publicado: (2020) -
Multiplex imaging reveals the architecture of the tumor immune microenvironment
por: Zhang, Junlei, et al.
Publicado: (2021)